Founderland Logofounderland
the ★ top ★ 100 ★ marketers ★
SavedSearch
FoundersFounders
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Product Launches
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Investment News
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Research & Innovation
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
FoundersFounders
Return

Company Page

FinalDose

Founders

Steven LinLi-Yao HuangJeff Liu

FinalDose is an Oxford-based health tech startup founded by Jeff Liu, a DPhil in Oncology from the University of Oxford. The company is building an AI and machine learning-powered platform aimed at relieving the burden of diet logging and delivering actionable analytics for people living with diabetes, with a broader mission of unfolding human potential through intelligent, science-backed digital health tools.

Company Founded in

Healthtech & Biotech iconHealthtech & Biotech

Articles about FinalDose

DNA-Triggered Drugs: Inside the Race to Cure 'Undruggable' Diseases

DNA-Triggered Drugs: Inside the Race to Cure 'Undruggable' Diseases

Healthtech & Biotech iconHealthtech & BiotechJun 29, 2026
The Race to Program DNA Drugs: Can Biotech Unlock Cancer's 80%?

The Race to Program DNA Drugs: Can Biotech Unlock Cancer's 80%?

Healthtech & Biotech iconHealthtech & BiotechJun 27, 2026
FinalDose's DNA-Targeting Drug Aims to Unlock 'Undruggable' Cancers

FinalDose's DNA-Targeting Drug Aims to Unlock 'Undruggable' Cancers

Healthtech & Biotech iconHealthtech & BiotechJun 12, 2026
Programmable DNA Drugs: The Race to Target 'Undruggable' Cancers

Programmable DNA Drugs: The Race to Target 'Undruggable' Cancers

Healthtech & Biotech iconHealthtech & BiotechJun 3, 2026
Can DNA-Targeting Drugs Crack 80% of 'Undruggable' Cancers?

Can DNA-Targeting Drugs Crack 80% of 'Undruggable' Cancers?

Healthtech & Biotech iconHealthtech & BiotechMay 28, 2026
The Race to Build Programmable DNA Drugs That Target Any Cancer

The Race to Build Programmable DNA Drugs That Target Any Cancer

Healthtech & Biotech iconHealthtech & BiotechMay 13, 2026
Y Combinator Biotech Targets 'Undruggable' Cancers With Programmable DNA

Y Combinator Biotech Targets 'Undruggable' Cancers With Programmable DNA

Healthtech & Biotech iconHealthtech & BiotechMay 12, 2026

About

Dreamwell AIContact UsOur Story

Articles

Product LaunchesInvestment NewsResearch & Innovation

founderland

We Use Cookies

We baked up some cookies – the digital kind. They help Draper run like a well-oiled mid-century machine. Some are essential to the experience, others help us tailor things to your taste. We promise, no crumbs on your blazer. Take a moment to choose what works for you.